The workforce reduction trend has swept the economy recently, and unfortunately, the medtech space is not immune to layoffs. You’ve probably read about the ongoing layoffs sweeping the tech industry, media and more. For instance, Yahoo, Disney, Zoom and more all reported workforce reductions as companies across industries grapple with economic pressures. Think inflation, supply […]
iCad Inc.
iCad AI tech accurately predicts breast cancer risk, provides heart disease insights
iCad (Nasdaq:ICAD) today announced plans to present new studies validating its AI-powered ProFound Breast Health Suite. ProFound helps to uncover hidden heart or vascular disease and predict a woman’s risk for developing breast cancer in the next 1-2 years. The platform can screen a single mammogram for two of the top causes of death for […]
iCad to integrate Google AI into mammography workflow
iCad (Nasdaq:ICAD) announced today that it amended its development and commercialization agreement with Google Health. The amendment enables iCad to integrate Google’s AI technology with its ProFound Breast Health Suite for 2D mammography. It intends to integrate the AI capabilities upon regulatory approval as an independent reader for breast cancer screening. ProFound Detection, a high-performance […]
iCad lays off 28% of its workforce in restructuring plan
iCad (Nasdaq:ICAD) announced that it enacted a restructuring plan that includes a workforce reduction of approximately 28%. The Nashua, New Hampshire-based cancer detection and therapy solution developer said that equates to approximately 23 employees. It attributed the restructuring plan to ongoing industry and macroeconomic pressures. iCad’s restructuring aims to support long-term strategic goals and reduce operating […]
iCad CEO Stacey Stevens resigns for personal reasons, Dana Brown named as replacement
iCad (Nasdaq:ICAD) announced today that it accepted the resignation — for personal reasons — of Stacey Stevens as president and CEO. Stevens, who took over the corner office in March 2022, plans to remain with the company through April 30, 2023. She intends to ensure a smooth transition to new president and CEO, Dana Brown. […]
iCad announces CFO transition
iCad (Nasdaq:ICAD) announced today that its board of directors approved the appointment of Daniel Shea as interim CFO. Shea takes over as interim CFO, effective immediately. The cancer detection and therapy tech company also launched a search for a full-time CFO. Steve Sarno previously held the interim CFO role. The company said in a news […]
iCad, Solis Mammography partner on AI for cardiovascular disease
iCad (Nasdaq:ICAD) announced today that it entered into a collaboration with Solis Mammography to define cardiovascular risk. The development and commercial collaboration revolves around producing an artificial intelligence (AI) solution. This solution potentially quantifies the presence of breast arterial calcifications in a mammogram to assess the risk of cardiovascular disease (CVD). It uses data obtained […]
iCad names Stacey Stevens as CEO
iCad (NSDQ:ICAD) today announced that it has appointed Stacey Stevens as president and CEO, effective March 1, 2022. Stevens has served as the Nashua, N.H.-based company’s president since 2019. She succeeds chairperson and CEO Michael Klein, who will continue to serve as chairperson of iCad’s board of directors. “We are currently at an important inflection point, […]
Latest iCad 3D mammography AI gains CE mark
iCad (NSDQ:ICAD) today announced that the third version of its ProFound AI for digital breast tomosynthesis (DBT) has won CE mark approval. Compared with previous software versions, the latest generation of ProFound AI offers up to a 10% improvement in specificity performance while maintaining a high sensitivity level, and approximately 40% faster processing on the new […]
iCad raises $12.5m
iCad (NSDQ:ICAD) announced that it entered into agreements for the purchase and sale of its common stock for gross proceeds of approximately $12.5 million. The agreements included the sale of more than 1.5 million shares of Nashua, N.H.-based iCad’s common stock at $8 per share. Craig-Hallum Capital Group is acting as financial advisor in connection with […]
iCad’s AI-assisted mammography tech wins CE Mark
iCad (NSDQ:ICAD) has won the CE Mark for its advanced artificial intelligence technology and workflow solution, ProFound AI for 2D mammography. The Nashua, N.H.-based cancer detection and radiation therapy devices maker developed the technology to boost breast cancer detection by identifying soft-tissue densities and calcifications. ProFound AI for 2D mammography is the latest addition to […]
